Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa

The South African national combination antiretroviral therapy (cART) roll-out program started in 2006, with over 4.4 million people accessing treatment since it was first introduced. HIV-1 drug resistance can hamper the success of cART. This study determined the patterns of HIV-1 drug-resistance ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Obasa, Adetayo Emmanuel, Mikasi, Sello Given, Brado, Dominik, Cloete, Ruben, Singh, Kamlendra, Neogi, Ujjwal, Jacobs, Graeme Brendon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099763/
https://www.ncbi.nlm.nih.gov/pubmed/32265875
http://dx.doi.org/10.3389/fmicb.2020.00438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099763/
https://www.ncbi.nlm.nih.gov/pubmed/32265875
http://dx.doi.org/10.3389/fmicb.2020.00438

Ejemplares similares